FDA (Devices) recall action 72651
The FDA (Devices) publishes a recall like this one as 59 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 59 pages.
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Ameditech is recalling 1 Step 12 Panel Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 6 Panel Dip Cards because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 6 Panel Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling iCup DX 10 Panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 12-Panel Dip Drug Screen kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 8 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 8 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling EDI BZO Uncut Sheet drug tests because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 9 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.